EC Number   |
Title |
Organism |
|---|
   2.3.1.26 | A phase 1 study of nevanimibe HCl, a novel adrenal-specific sterol O-acyltransferase 1 (SOAT1) inhibitor, in adrenocortical carcinoma |
Homo sapiens |
| 2.3.1.26 | Assessment of acyl-CoA cholesterol acyltransferase (ACAT-1) role in ovarian cancer progression - An in vitro study |
Homo sapiens |
| 2.3.1.26 | Biseokeaniamides A, B, and C, sterol O-Acyltransferase inhibitors from an Okeania sp. marine cyanobacterium |
Homo sapiens |
| 2.3.1.26 | Celludinones, new inhibitors of sterol O-acyltransferase, produced by Talaromyces cellulolyticus BF-0307 |
Homo sapiens |
| 2.3.1.26 | Celludinones, new inhibitors of sterol O-acyltransferase, produced by Talaromyces cellulolyticus BF-0307 |
Chlorocebus aethiops |
| 2.3.1.26 | Design and synthesis of simple, yet potent and selective non-ring-A pyripyropene A-based inhibitors of acyl-coenzyme A Cholesterol acyltransferase 2 (ACAT2) |
Homo sapiens |
| 2.3.1.26 | Design, synthesis and pharmacology of aortic-selective acyl-CoA Cholesterol O-acyltransferase (ACAT/SOAT) inhibitors |
Oryctolagus cuniculus |
| 2.3.1.26 | Enhanced acyl-CoA cholesterol acyltransferase activity increases cholesterol levels on the lipid droplet surface and impairs adipocyte function |
Mus musculus |
| 2.3.1.26 | Niemann-Pick C1-deficient mice lacking sterol O-acyltransferase 2 have less hepatic cholesterol entrapment and improved liver function |
Mus musculus |
| 2.3.1.26 | Selective inhibition of sterolO-acyltransferase 1 isozyme by beauveriolide III in intact cells |
Chlorocebus aethiops |
